Aim Bulletin

Tristel OPH gets US FDA clearance

By Josh White

Date: Monday 12 May 2025

(Sharecast News) - Tristel announced on Monday that it has received FDA clearance to begin immediate sales of its ophthalmic disinfectant foam, Tristel OPH, in the United States.
The AIM-traded firm said the high-level disinfectant was approved for use on a range of reusable ophthalmic instruments, including tonometers, retinal imaging probes,...

Sign up for free or to read the full story

Email this article to a friend

or share it with one of these popular networks:


Article Archive

Top of Page